Cancer risk in nodules detected at follow-up lung cancer screening CT

Cancer risk in nodules detected at follow-up lung cancer screening CT
(a) Present lung cancer screening CT and (b) lung cancer screening CT performed 2 years prior. Nodule described as growing pure ground-glass nodule (associated with cystic lesion), measuring 15 mm in mean diameter. Nodule categorized Lung-RADS 3 by clinical report, though Lung-RADS 2 by strict application of size criteria. Subsequent wedge resection demonstrated lepidic-predominant adenocarcinoma. Credit: American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

According to an article in ARRS' American Journal of Roentgenology (AJR), Lung-RADS—as applied by radiologists in clinical practice—achieved excellent performance for lung cancer risk assessment on follow-up screening CT examinations, although strict application did downgrade some malignancies.

Noting that volumetric assessments showed weaker performance than clinical Lung-RADS, "new nodules warrant smaller size thresholds than existing nodules," clarified coauthors Mark M. Hammer and Suzanne C. Byrne from Brigham and Women's Hospital at Harvard Medical School in Boston, MA.

The pair's retrospective study included 185 patients (100 women, 85 men; median age, 66 years) who underwent screening CT examinations for which a prior CT was available. To enrich that sample with suspicious nodules, Hammer and Byrne performed stratified , which yielded 50, 45, 47, 30, and 13 nodules with Lung-RADS categories 2, 3, 4A, 4B, and 4X, respectively. Extracting nodule linear measurements from clinical reports to generate Lung-RADS categories via strict criteria, a semiautomated tool was used to obtain nodule volumes, which then generated NELSON categories.

With 29 cancers diagnosed, the weighted risk was 5% for new nodules, 1% for stable existing nodules, and 44% for growing existing nodules. Whereas no clinical category 2 nodule was cancer, using strict Lung-RADS, 34 nodules, including 7 cancers, were downgraded to category 2. For clinical Lung-RADS categories, AUC was 0.96, compared with 0.71–0.84 for volumetric NELSON (two readers).

"Strict application of Lung-RADS criteria resulted in downgrading of numerous malignant nodules (typically on the basis of stability or pure ground-glass appearance), supporting use of category 4X for with suspicious features, even if stable," Hammer and Byrne added.

More information: Mark M. Hammer et al, Cancer Risk in Nodules Detected at Follow-up Lung Cancer Screening CT, American Journal of Roentgenology (2021). DOI: 10.2214/AJR.21.26927
Citation: Cancer risk in nodules detected at follow-up lung cancer screening CT (2021, November 10) retrieved 4 December 2022 from https://medicalxpress.com/news/2021-11-cancer-nodules-follow-up-lung-screening.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Reduced vs. standard CT dose for lung nodules in children, young adults with cancer

2 shares

Feedback to editors